The Trump Administration’s sluggish transition process may foreshadow fundamental changes to the administrative state, Peter Strauss argues at Take Care.
The Senate Committee on Health, Education, Labor and Pensions questioned President Trump’s nominee to lead the Food and Drug Administration (FDA), Dr. Scott Gottlieb, in hearings on Wednesday (NYT, WaPo).
The Project on Government Oversight comments on President Trump’s proposed increase of funding from drug companies for the Food and Drug Administration.
Retired Gen. Stanley MyChrystal argues that pitting funding for public broadcasting and military expenditures against one another is a “false choice,” and that both make Americans safer (NYT).
Increased use of the Congressional Repeal Act to undo regulations promulgated by prior administrations may lead to more hastily developed regulations that undermine regulatory effectiveness, Stuart Shapiro explains (RegBlog).
At Just Security, Ganesh Sitaraman analyzes the national security consequences of deregulation.
President Trump lacks plenary power to regulate Indian Affairs, Seth Davis argues at Take Care.